by Catalin | Jun 26, 2026 | 2026 vol. 4 Issue 2
Challenges in the management of DLBCL in Pregnancy – A Case Report Stefan-Antoniu AIONESE, Mihaela CIRSTEA, Oana RIZEA, Aurelia TATIC Introduction: Lymphomas comprise a heterogeneous group of lymphoid malignancies and represent the fourth most common malignancy...
by Catalin | Jun 26, 2026 | 2026 vol. 4 Issue 2
Whispers from the Liver: A Hidden Case of CD10+ High-Grade B-cell Lymphoma Nasim SALIMIAGHDAM, Ummi KHAN, Ruchit SHAH Background: High-grade B-cell lymphomas involving the liver are rare and often present with vague, nonspecific symptoms. Clinically, these lymphomas...
by Catalin | Jun 26, 2026 | 2026 vol. 4 Issue 2
A Retrospective Study of Sickle Cell Disease Patients’ Clinical and Laboratory Data as Predictors of Disease Morbidity and Mortality in a Single Center (KFHU), Saudi Arabia Baneen ALJISHI, Yasser OSMAN Objectives: Sickle cell disease (SCD) is an autosomal recessive...
by Catalin | Jun 26, 2026 | 2026 vol. 4 Issue 2
Prognostic Factors in Polycythemia Vera Sandor-Szilard PORTIK, Laura URIAN, Mihnea ZDRENGHEA, Anca VASILACHE, Tunde TOROK, Andrada PARVU, Ciprian TOMULEASA, Delia DIMA, Ioana RUS, Oana MESAROS, Laura JIMBU, Anca BOJAN Introduction: Polycythemia vera is a chronic...
by Catalin | Jun 26, 2026 | 2026 vol. 4 Issue 2
Real-World Outcomes and Morphological Patterns of Aggressive Non-Hodgkin Lymphoma in Moldova: A Five-Year Retrospective Cohort Study Artur ANTOSEL, Cristina DUDNIC, Maria ROBU, Sanda BURUIANA, Victor TOMACINSCHII Objectives: The addition of rituximab to CHOP...
by Catalin | Jun 26, 2026 | 2026 vol. 4 Issue 2
Triple Therapy with Azacitidine, Venetoclax and Gilteritinib as a Therapeutic Option for Adult Patients with Refractory/Relapsed FLT3 Mutated Acute Myeloid Leukemia – A Single Center Experience Dana FRANGU, Roxana HIRJAN, Bianca CONSTANTIN, Andreea ANDRUNACHE, Mihaela...
